CNN cardia bioplastics limited

ann: year end results - material variances

  1. 12,617 Posts.
    lightbulb Created with Sketch. 181
    YEAR END RESULTS- MATERIAL VARIANCES
    In accordance with Listing Rule 3.1, the Company wishes to advise of the following material variances to its year end results to June 2013 compared to that of the corresponding period last year.
    The Company is expecting an improved loss position for the year ending to June 2013 (approx loss of $3.06 million) in comparison to last year (loss of $4.66 million).
    The major items affecting the financial results (based on internal management accounts) for the year to June 2013 are:
    Revenue
    Revenue for the year has increased by 23.88% to $5,833,739 as compared to the revenue of
    $4,709,106 last year. The increase in revenue is a result of:
    ? Overall increase in Sales by 17.42% or $749,432 compared to last year ($4,301,143).
    ? R&D Tax Credits of $770,710 received during the year as compared to receipt of $343,426
    last year.
    Loss Position
    The Company’s has recorded a loss of $1,621,095 from its operating activities for the year, an improvement of 58.48% or $2,283,311 compared to last year ($3,904,406).
    The improved loss position is due to cost savings from the restructuring measures that have been put in place from June’12 Quarter.
    Further, after recognising impairment loss of $1,439,045 on its intangible assets (Goodwill) as at 30 June 2013, the Company’s consolidated loss position for the year has improved by 34.33% or $1,599,520 compared to a loss of $4,659,660 last year.
    ????
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.